Latest Announcements

BSE & NSE corporate filings with AI summaries

NSEPress Release▲ PositiveResults29 Oct 2026

Asset Reconstruction Company (India) Limited

Press Release

Asset Reconstruction Company (India) Limited has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with a 21% YoY growth in AUM to Rs. 20,274 crore and a 54% YoY increase in PAT to Rs. 290.0 crore.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults29 Oct 2026

ICRA Limited

Outcome of Board Meeting

ICRA Limited has informed the Exchange regarding Outcome of Board Meeting held on October 29, 2026. The company has approved the standalone and consolidated financial results for the quarter and six months ended September 30, 2026.

Read more →📎 1 attachment
NSEGeneral Updates▲ PositiveResults29 Oct 2026

Strides Pharma Science Limited

General Updates

Strides Pharma Science Limited has announced its Q2 and H1FY27 earnings, with revenue growing 17% YoY to ₹14,297m and ₹26,951m respectively, driven by Ex-US Markets. EBITDA grew 8% YoY to ₹2,509m and ₹4,807m respectively, despite higher raw material, freight and operating costs. Net Debt increased by ₹2,114m during H1 due to an elongated cash-to-cash cycle and higher inventory holding.

Read more →📎 1 attachment
NSERecord Date▲ PositiveResults29 Oct 2026

Sanofi India Limited

Record Date

Sanofi India Limited has announced its financial results for the quarter ended September 30, 2026, with a 2% growth in domestic net sales and a 4% growth in total net sales compared to the third quarter of 2025. The company has also declared an interim dividend of Rs. 75 per equity share and fixed November 5, 2026, as the record date for the payment of the dividend.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults29 Oct 2026

Sanofi India Limited

Press Release

Sanofi India Limited has announced its Q3 2026 financial results, reporting a 2% growth in domestic net sales and a 4% growth in total net sales compared to the third quarter of 2025. The company's Insulin portfolio delivered a 9% growth in Q3'26, cementing its leadership in the Diabetes Injectable segment with a 55% market share.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults29 Oct 2026

Capital Small Finance Bank Limited

Press Release

Capital Small Finance Bank Limited has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with Gross Advances increasing to ₹9,755 crore, total Deposits rising to ₹10,831 crore, and Profit After Tax standing at ₹45.61 crore.

Read more →📎 1 attachment
NSECopy of Newspaper PublicationResults29 Oct 2026

Bandhan Bank Limited

Copy of Newspaper Publication

Bandhan Bank Limited has announced its unaudited financial results for the quarter (Q2) and half-year ended September 30, 2026, with a net profit of ₹62,175.05 crore and ₹1,12,341.92 crore respectively.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults29 Oct 2026

Capital Small Finance Bank Limited

Investor Presentation

Capital Small Finance Bank Limited has released its investor presentation for the period ended September 30, 2026, highlighting its unaudited financial results, including a 23.4% YoY growth in loan book, 16.2% YoY growth in deposits, and a 31% YoY growth in profitability.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults29 Oct 2026

Asset Reconstruction Company (India) Limited

Outcome of Board Meeting

Asset Reconstruction Company (India) Limited has announced the outcome of its board meeting, where it approved the financial results for the quarter and half year ended September 30, 2026, re-appointed an independent director, and appointed a senior management personnel.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults29 Oct 2026

Steamhouse India Limited

Investor Presentation

Steamhouse India Limited has submitted its Investor Presentation for Q2 & H1 FY27, highlighting a strong year-on-year performance despite seasonal moderation, with a 12.06% year-on-year growth in steam supply volumes and a focus on sustaining growth momentum.

Read more →📎 1 attachment
NSEUpdatesResults29 Oct 2026

Jet Freight Logistics Limited

Updates

Jet Freight Logistics Limited has informed the Exchange regarding the availability of the audio recording of the Analysts/Investors Earning Conference Call pertaining to the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults29 Oct 2026

Strides Pharma Science Limited

Press Release

Strides Pharma Science Limited has announced its Q2FY27 financial results, with revenue growing 17% YoY to ₹14,297m, driven by Ex-US Markets, and EBITDA up 8% YoY to ₹2,509m, crossing ₹2,500m in a quarter for the first time.

Read more →📎 1 attachment
NSEGeneral UpdatesResults29 Oct 2026

Jet Freight Logistics Limited

General Updates

Jet Freight Logistics Limited has informed the Exchange about General Updates, providing a link to the audio recording of the Earning Conference Call for the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026.

Read more →📎 1 attachment
← PreviousPage 260 of 1427Next →